-
HC Wainwright Reiterates Buy Rating for Esperion Therapeutics (NASDAQ:ESPR)
Source: Buzz FX / 19 Nov 2024 07:36:09 America/Chicago
HC Wainwright Reiterates Buy Rating for Esperion Therapeutics (NASDAQ:ESPR) Written by MarketBeat November 19, 2024 Share Link copied to clipboard. Esperion Therapeutics ( NASDAQ:ESPR - Get Free Report ) 's stock had its "buy" rating reaffi
Read more...